Business Segments · Capital expenditures, gross
Life Sciences — Capital expenditures, gross
Danaher Life Sciences — Capital expenditures, gross increased by 42.5% to $57.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 75.1%, from $229.00M to $57.00M. Over 2 years (FY 2023 to FY 2025), Life Sciences — Capital expenditures, gross shows a downward trend with a -23.8% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ4 2025
How to read this metric
Higher spending indicates investment in future capacity, while lower spending may suggest a focus on cash preservation or completed expansion cycles.
Detailed definition
The total cash outflow for the acquisition or improvement of long-term physical assets within the Life Sciences segment....
Peer comparison
Standard metric for capital investment; peers in the life sciences space will report similar figures based on their growth stage.
Metric ID:
dhr_segment_life_sciences_capital_expenditures_grossHistorical Data
12 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $80.00M | $80.00M | $80.00M | $80.00M | $60.00M | $50.00M | $52.00M | $229.00M | $48.00M | $41.00M | $40.00M | $57.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -25.0% | -16.7% | +4.0% | +340.4% | -79.0% | -14.6% | -2.4% | +42.5% |
| YoY Change | — | — | — | — | -25.0% | -37.5% | -35.0% | +186.3% | -20.0% | -18.0% | -23.1% | -75.1% |
Range$40.00M – $229.00M
CAGR-11.6%
Avg YoY Growth-5.9%
Median YoY Growth-24.0%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — capital expenditures, gross?
- Danaher (DHR) reported life sciences — capital expenditures, gross of $57.00M in Q4 2025.
- How has Danaher's life sciences — capital expenditures, gross changed year-over-year?
- Danaher's life sciences — capital expenditures, gross decreased by 75.1% year-over-year, from $229.00M to $57.00M.
- What is the long-term trend for Danaher's life sciences — capital expenditures, gross?
- Over 2 years (2023 to 2025), Danaher's life sciences — capital expenditures, gross has grown at a -23.8% compound annual growth rate (CAGR), from $320.00M to $186.00M.
- What does life sciences — capital expenditures, gross mean?
- Total spending on physical assets like machinery and facilities for the Life Sciences unit.